United States

Opexa Therapeutics Inc (OPXA.PH)

OPXA.PH on Philadelphia Stock Exchange

21 Feb 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Fri, Nov 25 2016

BRIEF-Opexa Therapeutics receives notice from Ares Trading S.A. Unit of Merck Serono

* Opexa Therapeutics - On Nov 23, co received notice from Ares Trading S.A. Unit of Merck Serono

BRIEF-Opexa Therapeutics reports qtrly loss per share of $0.28

* Opexa Therapeutics Inc reports qtrly option revenue $726,291 versus $726,291 last year

BRIEF-Opexa Therapeutics qtrly loss per share $0.28

* Opexa -believes has sufficient liquidity to support current activities in winding down abili-t trial and for general operations

BRIEF-Opexa Therapeutics announced workforce cut of about 40 pct on Nov. 2 - SEC Filing

* On November 2, 2016, co announced an approximately 40% reduction to company's then-current workforce

BRIEF-Opexa Therapeutics says failed in mid-stage study

* Opexa therapeutics inc - on oc 28, co announced top-line results from its phase 2b "abili-t" clinical trial

Select another date:

More From Around the Web